H.R. 2672/S. 1423, the Preserving Access to Orphan Drugs Act of 2011: Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million.Device Tax LegislationHR4213 -The tax Extenders Act of 2009; HR5297; The Small Business Jobs and Credit Act and HR 4853: The tax relief, unemployment Insurance Reauthorization and job Creation Act of 2010, as they related to the R&D tax credit ; Device Tax Legislation 

HR 3630, Middle Class Tax Relief and Job Creation Act (this is the payroll tax relief extension bill)
S. 1813, MAP-21 Act (the Senate highway bill with pension relief)
HR 4196 and S.2240, extension of bonus depreciation

S.2240/HR 4196, to extend bonus depreciation; and S. 2237, the Small Business Jobs and Tax Relief Act, as it relates to bonus depreciation.  S. 1813/HR 4348, MAP-21, as it relates to pension funding relief.  Issues related to the R&D tax credit, the taxation of U.S. multinational corporations and corporate tax reform. 

S. 3521, The Family and Business Tax Cut Certainty Act of 2012, HR 8, the American Taxpayer Relief Act. S.296, H.R. 2245 Preserving Access to Life-Saving Medications Acts; 340B Drug Discount; H.R. 1483 , Drug Safety Enhancement Act; Devise Tax; AdvaMed Competitiveness Agenda; 510(k) Clearance Reforms; FDA Regulatory Environment.  Raise awareness with legislators about the benefits of home dialysis and try to increase awareness in the veteran population.HELP and Energy and Commerce Drug shortage draft legislation. S. 3187, Food and Drug Administration Safety and Innovation Act.  MDUFA, PDUFA, BSUFA, GDUFA. Traceability and drug supply chain reforms. Medical device reforms. Medical Gases Safety Act. 
Raise Awareness with legislators about survey and certification issues as it relates to home dialysis.
Seeking appropriate reimbursement and access for an investigational indication of our product, GammaGard, to treat Alzheimers Disease. HR 1845/S 960: Provide supplies and nursing services necessary for home infusion of IVIG to Medicare beneficiaries with Primary Immunodeficiency Diseases; Legislation to cut Medicare Part B Drug Reimbursement.Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis.HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure.
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BAXTER HEALTHCARE CORPORATION
1501 K STREET, NW, SUITE 375, WASHINGTON, DC, 20006, US
JED PERRY JACK MANIKO JOSEPH V SCHWAN JACK MANIKO KELLI MILLS LESTER MARK COIN JED PERRY JED PERRY JACK MANIKO MOLLY RYAN MARK COIN KELLI MILLS LESTER JOSEPH V SCHWAN